您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > MK-571 sodium
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
MK-571 sodium
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
MK-571 sodium图片
CAS NO:115103-85-0
包装与价格:
包装价格(元)
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
1 mL*10 mM(in DMSO)电议

产品名称
MK-571 sodium salt
Verlukast sodium
L-660711
L-660711 sodium salt
Propanoic acid
MK571
L-660711 (sodium salt)
产品介绍
MK-571 sodium 是一种可口服的选择性白三烯D4受体拮抗剂,在豚鼠和人肺膜的Ki分别为0.22 和 2.1 nM。

产品描述

MK-571 is a selective, orally active antagonist of the CysLT1 receptor. MK571 is a multidrug resistance protein-2 (ABCC2, Mrp2) inhibitor used to demonstrate the role of Mrp2 in the cellular efflux of drugs, xenobiotics, and their conjugates. MK571 can inhibit the synthesis of K-4′-O-GlcA (19.7 μM). MK571 dose-dependently inhibits the intracellular biosynthesis of all flavonol sulphates and glucuronides by Caco-2 cells. MK571 significantly inhibits phase-2 conjugation of kaempferol by cell-free extracts of Caco-2, and production of kaempferol-4′-O-glucuronide was competitively inhibited. In addition to inhibiting MRP2, MK571 is a potent inhibitor of enterocyte phase-2 conjugation.

体外活性

MK-571在健康年轻人体内耐受性良好.口服可被迅速吸收,血药浓度在给药后1.1-1.5 h后达峰.

体内活性

在类肺部,MK-571可抑制[3H]LTD4的结合(Ki:2.1±1.8 nM,n=29),而在豚鼠肺中的Ki值为0.22±0.15 nM (n=35)。但其对[3H]LTC4的结合活性较低或没有活性(IC50:32 μM,n=1,人;23±11 μM,n=16,豚鼠)。

细胞实验

Cells were seeded onto 96 well plates at a concentration of 1×103 cells per well and incubated for 72 h at 37?C and 5% CO2 to allow MRP1 messenger RNA suppression to occur. Cells were then treated with either control media or one of three chemotherapy drugs temozolomide (150 µM), vincristine (100 nM), or etoposide (2 µM). Cells were then returned to the incubator for a further 72 h; after which time, Metylthiazol Tetrazolium (MTT) powder in PBS (50µl of 5 mg/ml) was added to each well. Cells were then incubated for a further 4 h after which all solution was removed and dimethyl sulfoxide (DMSO) was added. After 10 min incubation time at 37?C, absorbance was recorded at 570 nm wavelength and data was recorded and analyzed. Small molecule inhibitors MK571 (25 µM) and Reversan (15µM) were added 7 h prior to carrying out further drug treatment (temozolomide, vincristine or etoposide) or assay assessment (media change for proliferation and 2D-migration assays) (Only for Reference)

Cas No.

115103-85-0

分子式

C26H26ClN2NaO3S2

分子量

537.06

别名

MK-571 sodium salt;Verlukast sodium;L-660711;L-660711 sodium salt;Propanoic acid;MK571;L-660711 (sodium salt)

储存和溶解度

DMSO:93 mg/mL (173.2 mM)
H2O:<1 mgml
Ethanol:16 mg/mL (29.8 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years